Physician

Marwan Purghol, MD

According to 2025 Medicare claims, Marwan Purghol, MD (NPI: 1689607350) practices neurology in the Beaumont-Port Arthur, TX market, with the plurality of this provider's patient population coming from Jefferson, TX. This provider's primary affiliated billing organization is NEUROLOGY ASSOCIATES OF SOUTHEAST TEXAS, P.L.L.C. (NPI: 1528197712; TIN: 342026380) and primary practice location at 77627-6258.

Purghol's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 299 traditional Medicare patients, billed 63,315 HCPCS/CPT codes, and received $439,804 in Medicare payments. The top billing code was 95819 (Measurement of brain wave activity (eeg), awake and asleep). Part D data shows 2,362 prescription claims across 398 beneficiaries totaling $246,642 in drug costs, led by Botox (Onabotulinumtoxina). 2020 DME data shows 31 claims. Open Payments data shows 13 records totaling $358. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $242,556 to $439,804. In contrast, Part D prescription costs have moved from a higher plateau to a lower plateau, from $536,801 to $246,642. For DME billing, this smaller-volume category moved sharply higher in recent years, from $2,914 to $1,727.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	529	15,497	$242,556
2016	415	17,535	$228,051
2017	370	16,926	$205,304
2018	332	14,946	$184,176
2019	368	23,366	$262,756
2020	300	26,926	$221,903
2021	295	33,603	$272,225
2022	287	47,504	$338,563
2023	303	50,814	$373,737
2024	299	63,315	$439,804

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	441	3,409	$536,801
2016	440	3,652	$565,318
2017	453	3,627	$471,566
2018	458	3,479	$562,563
2019	459	3,459	$510,733
2020	422	3,340	$306,935
2021	424	3,171	$305,798
2022	429	2,901	$375,936
2023	390	2,303	$238,338
2024	398	2,362	$246,642

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	54	$1,091
2016	N/R	N/R	N/R
2017	N/R	15	$509
2018	N/R	15	$463
2019	N/R	63	$1,631
2020	N/R	31	$756
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95819	Measurement of brain wave activity (eeg), awake and asleep	67	68	$317
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	76	106	$128
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	78	78	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	198	268	$85
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	251	389	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Botox	Onabotulinumtoxina	49	4,272	$97,681
Qulipta	Atogepant	33	1,320	$45,448
Pregabalin	Pregabalin	203	8,603	$7,207
Rytary	Carbidopa/Levodopa	22	907	$7,029
Memantine Hcl	Memantine Hcl	273	14,730	$4,534

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$358	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Marwan Purghol, MD?

Tedicare shows public-source Medicare data for Marwan Purghol, MD (NPI 1689607350), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marwan Purghol, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Marwan Purghol, MD?

Marwan Purghol, MD is linked to NEUROLOGY ASSOCIATES OF SOUTHEAST TEXAS, P.L.L.C. (billing NPI 1528197712) in the available physician profile data.

Does Marwan Purghol, MD have Open Payments data?

Marwan Purghol, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.